Latest Lead News

Tivan Limited has made significant strides in its critical minerals portfolio, securing a $51.3 million strategic investment and progressing key feasibility studies across multiple projects.

Anteris Technologies has launched a $200 million public offering alongside a $90 million strategic investment from Medtronic, aiming to accelerate its DurAVR heart valve clinical trials and manufacturing expansion.

Aurelia Metals has delivered robust metal production and cash flow in Q2 FY26, reaffirming its full-year guidance while advancing key growth projects on schedule.

Litchfield Minerals has completed its first field reconnaissance at the Silver Valley Project, revealing well-developed quartz reefs and visible sulphide mineralisation. The company is set to launch a geophysical survey to pinpoint drill targets for 2026.

Rio Tinto delivered a standout 2025 with an 8% rise in copper equivalent production, record iron ore output in the Pilbara, and key milestones like the first shipment from Simandou port. The company met or exceeded its guidance while advancing major projects across its portfolio.

Vault Minerals delivered a robust December quarter with 76,520 ounces of gold produced and significant progress on its King of the Hills processing plant expansion, positioning the company for higher throughput and full exposure to gold prices after closing its hedge book.

Kingfisher Mining has completed a strategic acquisition of 11 tenements in New South Wales and commenced drilling at the Copper Blow IOCG prospect, while advancing rare earth element exploration in Western Australia.

Telix Pharmaceuticals has met its upgraded FY 2025 revenue guidance with US$804 million, driven by strong growth in its Precision Medicine segment and the successful US launch of Gozellix. The company also advanced multiple clinical trials and announced a strategic collaboration with Varian to combine radiopharmaceuticals with radiation therapy.

EcoGraf’s maiden exploration in Tanzania delivers promising high-grade gold results, including a standout 4.45 g/t sample at Hazina, while a strategic farm-in with AngloGold Ashanti begins on the Golden Eagle project.

Finbar Group has achieved over 70% presales for its Palmyra West Apartments project, signalling strong market demand ahead of construction starting in March 2026.

Neurizon Therapeutics has secured trademark protection for its NEURIZON® brand across major pharmaceutical markets, reinforcing its intellectual property strategy as it advances its lead drug candidate NUZ-001.

FBR Limited has secured a binding conditional purchase order worth AUD 990,000 from a leading US heavy equipment dealer for its Mantis welding robot, marking a significant milestone during its prototyping phase.